文献速递产科

FAS A-670G与Fas配体IVS2nt A 124G多态性在子痫前期女性中显著增加并可能促成HELLP综合征:一项病例对照研究

FAS A-670G and Fas ligand IVS2nt A 124G polymorphisms are significantly increased in women with pre-eclampsia and may contribute to HELLP syndrome: a case-controlled study.
PubMed 文献 · BJOG · 2018-09-03

在突尼斯大学医院开展病例对照研究,纳入300例子痫前期孕妇与300例年龄匹配健康孕妇。Fas-670G变异频率在子痫前期组42%高于对照组30%(P<0.001),FasL IVS2nt 124G频率43%高于30%(P<0.001)。携带Fas-670G与肝酶升高相关,提示HELLP综合征患病率增加。

要点

  • 子痫前期组Fas-670G变异频率42%高于对照组30%(P<0.001)。
  • 子痫前期组FasL IVS2nt 124G频率43%高于对照组30%(P<0.001)。
  • 携带Fas-670G与肝酶升高相关,提示HELLP综合征患病率增加。

核心结论

  • Fas-670G和FasL IVS2nt 124G多态性与子痫前期及其并发症风险升高相关。

研究设计与样本

  • 病例对照研究,在突尼斯大部分地区的大学医院招募300例子痫前期孕妇和300例年龄匹配的健康孕妇。
  • 采用聚合酶链反应-限制性片段长度多态性方法对Fas-670A/G和FasL IVS2nt 124A/G基因多态性进行基因分型。

主要发现

  • Fas-670G变异频率在子痫前期组为42%,高于对照组的30%(P<0.001)。
  • FasL IVS2nt 124G变异分布在子痫前期组为43%,高于对照组的30%(P<0.001)。
  • 携带Fas-670G与肝酶升高相关,提示溶血、肝酶升高和低血小板(HELLP)综合征患病率增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We evaluated the association between the Fas-670A/G and the Fas ligand FasL IVS2nt 124 A/G polymorphisms and the risk of pre-eclampsia and its complications. DESIGN: A case-controlled study. SETTING: University Hospitals in most areas of Tunisia. POPULATION: We recruited 300 pregnant women who developed pre-eclampsia and 300 age-matched healthy pregnant women from the same hospital. METHODS: Genotyping of Fas-670A/G and the FasL IVS2nt 124A/G gene polymorphisms were conducted using polymerase chain reaction-restriction fragment length polymorphism among our cohort. MAIN OUTCOME MEASURES: Fisher's exact test was used to compare the statistical differences between groups for categorical variables and Student t tests were used for continuous variables. RESULTS: The frequency of the Fas-670G gene variant was significantly increased in women with pre-eclampsia (42%) compared with control women (30%; P < 0.001). Also, a statistically significant difference was obtained in the distribution of the FasL IVS2nt 124G gene variant when comparing women with pre-eclampsia (43%) with controls (30%; P < 0.001). Interestingly, we found that the carriage of Fas-670G was associated with increased liver enzymes, suggesting an increased prevalence of the haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome, a pre-eclampsia complication. CONCLUSION: The Fas-670G and FasL IVS2nt 124G polymorphisms are associated with a higher risk of pre-eclampsia and its complications. TWEETABLE ABSTRACT: Polymorphisms in the Fas and FasL genes are associated with increased risk of pre-eclampsia and HELLP syndrome.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Raguema N, Zitouni H, Ben Ali Gannoun M, et al. FAS A-670G and Fas ligand IVS2nt A 124G polymorphisms are significantly increased in women with pre-eclampsia and may contribute to HELLP syndrome: a case-controlled study. BJOG. 2018. PMID: 30066360. doi:10.1111/1471-0528.15412

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。